Nurse Loses Drug-Prescribing Rights in Swift DEA Revocation
Published Date: 2/21/2025
Notice
Summary
Jason Weakley, a nurse practitioner, lost his DEA registrations for Vermont and New Hampshire because he no longer has permission to handle controlled substances in those states. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his certificates. This means he can’t legally prescribe or manage controlled drugs in these states anymore, effective immediately.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
DEA Registrations Revoked; Renewals Denied
The DEA revoked Jason Weakley’s Certificates of Registration Nos. MW7073757 (Vermont) and MW7551460 (New Hampshire), so he cannot legally prescribe, dispense, or handle controlled substances in Vermont or New Hampshire. The Order also denies any pending applications to renew, modify, or obtain additional registration in those two states. The Order is effective March 24, 2025; the record shows his Vermont RN and APRN licenses were expired and suspended as of January 15, 2024, and his New Hampshire RN and APRN licenses expired March 23, 2024.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20227, St. Michael's Pharmacy; Decision and Order
St. Michael's Pharmacy in Texas had its DEA license suspended and is facing revocation because it kept filling risky drug prescriptions without fixing obvious warning signs of abuse. This affects the pharmacy’s ability to legally handle controlled substances and could impact patients relying on it. The pharmacy must now deal with these serious legal actions, which started in late 2025 and could lead to permanent closure or fines.
2026-20226, By Grace Inc. Counseling Services; Decision and Order
By Grace Inc. Counseling Services in Baltimore faced losing its DEA license because it didn’t keep good records and lied about its owner’s past drug conviction. After a hearing, the DEA decided to revoke their registration, meaning they can’t legally handle controlled substances anymore. This affects the clinic’s ability to operate and could impact patients relying on their services.
Previous / Next Documents
Previous: 2025-02935, Combined Notice of Filings
The Federal Energy Regulatory Commission got new requests from natural gas companies to change pipeline rates and agreements starting as soon as February 1, 2025. These changes could affect how much customers pay or get refunded. If you want to speak up or get involved, you need to act by the listed deadlines in February and March.
Next: 2025-03023, Sunshine Act Meetings
The National Council on Disability is holding a two-day meeting on March 6-7, 2025, both in Washington, DC, and online. They’ll discuss important topics like tax issues for disabled workers, disaster experiences, and ethics training, with a special chance for the public to share their thoughts. This meeting affects people with disabilities, advocates, and anyone interested in disability rights, with no new costs but plenty of fresh ideas and updates.